Tower Research Capital (TRC)’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.47K | Sell |
|
|||||
|
2025
Q1 | $13.4K | Sell |
|
|||||
|
2024
Q4 | $12K | Buy |
|
|||||
|
2024
Q3 | $7.48K | Sell |
|
|||||
|
2024
Q2 | $38.9K | Buy |
|
|||||
|
2024
Q1 | $18.4K | Buy |
|
|||||
|
2023
Q4 | $10.7K | Sell |
|
|||||
|
2023
Q3 | $14.1K | Buy |
|
|||||
|
2023
Q2 | $7.26K | Buy |
|
|||||
|
2023
Q1 | $3K | Sell |
|
|||||
|
2022
Q4 | $5K | Sell |
|
|||||
|
2022
Q3 | $33K | Sell |
|
|||||
|
2022
Q2 | $28K | Buy |
|
|||||
|
2022
Q1 | $6K | Buy |
|
|||||
|
2021
Q4 | $5K | Buy |
|
|||||
|
2021
Q3 | $2K | Sell |
|
|||||
|
2021
Q2 | $30K | Buy |
|
|||||
|
2021
Q1 | $15K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $14K | Buy |
|
|||||
|
2020
Q2 | $12K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $13K | Sell |
|
|||||
|
2015
Q2 | $45K | Buy |
|
|||||
|
2015
Q1 | $2K | Sell |
|
|||||
|
2014
Q4 | $57K | Buy |
|
|||||
|
2014
Q3 | $51K | Buy |
|
|||||
|
2014
Q2 | $8K | Buy |
|